Comparison of cure rates and durations of treatment with diphenylcyclopropenone immunotherapy for warts in children/adolescents and adults
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Ho Song | - |
dc.contributor.author | Lee, Min Won | - |
dc.contributor.author | Paek, Jun Oh | - |
dc.contributor.author | Yu, Hee Joon | - |
dc.contributor.author | Kim, Joung Soo | - |
dc.date.accessioned | 2022-07-16T02:54:58Z | - |
dc.date.available | 2022-07-16T02:54:58Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2014-10 | - |
dc.identifier.issn | 0011-9059 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/159043 | - |
dc.description.abstract | Background Immunotherapy has been used for many years in the treatment of warts. Diphenylcyclopropenone is frequently used as an immunotherapeutic agent. Methods A total of 143 patients with 180 cases of warts were included in this study. We divided the patients into two groups: 72 children/adolescents and 71 adults aged 20 and over. We evaluated two types of sensitization reaction, using an erythema and blister index and a pruritus index. Results Of the 180 cases of warts, 159 (88.3%) were completely cured: 86 (92.5%) of the 93 cases in children/adolescents and 73 (83.9%) of the 87 cases in adults. The time required for complete cure was 17.72 +/- 2.69 weeks in children/adolescents and 22.92 +/- 2.59 weeks in adults (P < 0.05). Conclusions Diphenylcyclopropenone immunotherapy can be used effectively for both children/adolescents and adults. The time required for complete cure is shorter in children/adolescents than in adults. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.title | Comparison of cure rates and durations of treatment with diphenylcyclopropenone immunotherapy for warts in children/adolescents and adults | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Joung Soo | - |
dc.identifier.doi | 10.1111/ijd.12377 | - |
dc.identifier.scopusid | 2-s2.0-84907807522 | - |
dc.identifier.wosid | 000342816600035 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF DERMATOLOGY, v.53, no.10, pp.1293 - 1298 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF DERMATOLOGY | - |
dc.citation.title | INTERNATIONAL JOURNAL OF DERMATOLOGY | - |
dc.citation.volume | 53 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1293 | - |
dc.citation.endPage | 1298 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.subject.keywordPlus | SQUARIC ACID DIBUTYLESTER | - |
dc.subject.keywordPlus | ALOPECIA-AREATA | - |
dc.subject.keywordPlus | TOPICAL IMMUNOTHERAPY | - |
dc.subject.keywordPlus | DINITROCHLOROBENZENE | - |
dc.subject.keywordPlus | DIPHENCYPRONE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.